Please assess the completion status of the following clinical trial:

Trial Title: CD8 Reactivity to Microorganisms in Blood and Breast Milk

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
-INCLUSION CRITERIA:~1. Age 18+ years.~2. Willing to allow storage of blood, breast milk, and cells for future research.~3. Willing to have genetic testing performed.~4. Meets one of the 3 following criteria:~   1. Confirmed exposure:~      -Exposure has been verifiably documented (eg, receiving an immunization or DNCB sensitization treatment).~      OR~      -Clinical history is consistent with established epidemiology of the microbe of interest (eg, documentation of past infection; or to a lesser priority travel to endemic areas or living with an individual that suffers from chronic infection with the targeted microbe).~      AND~      -Positive results on established clinical immunity tests (eg, viral RNA, antibody titers, etc).~  2. Suspected exposure: Clinical history is consistent with established epidemiology of the microbe of interest (eg, travel to endemic areas, documentation of past infection) but no established clinical assay exists to verify exposure.~  3. Non-exposed: Absence of exposure to targeted microorganisms as measured by lack of exposure to infected individuals, lack of travel to endemic areas, no immunization history, negative screening tests, or other methods of establishing exposure history to mucosal microbial agents.~EXCLUSION CRITERIA:~1. Active use of immunosuppressive medications.~2. Any condition that, in the opinion of the investigator, contraindicates participation in this study.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 99 Years
- Healthy Volunteers: f

Study Arms:
- Controls (Type: None): non exposed controls
- donors with naturally enriched antimicrobial blood samples and (Type: None): Donors with naturally enriched antimicrobial blood samples an breast milk, Comparisons will be made with non exposed controls.

Based on this trial design, predict the completion outcome and termination type (if applicable).